Veery Capital LLC Has $266,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Veery Capital LLC trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 8.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 654 shares of the company’s stock after selling 58 shares during the period. Veery Capital LLC’s holdings in HCA Healthcare were worth $266,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Natixis Advisors LLC grew its stake in HCA Healthcare by 2.3% in the third quarter. Natixis Advisors LLC now owns 110,105 shares of the company’s stock valued at $44,750,000 after purchasing an additional 2,459 shares in the last quarter. Mizuho Securities USA LLC increased its holdings in HCA Healthcare by 205.4% during the third quarter. Mizuho Securities USA LLC now owns 45,637 shares of the company’s stock worth $18,548,000 after buying an additional 30,693 shares during the last quarter. Simplify Asset Management Inc. grew its position in shares of HCA Healthcare by 67.1% in the 3rd quarter. Simplify Asset Management Inc. now owns 2,351 shares of the company’s stock valued at $956,000 after acquiring an additional 944 shares during the period. Valley Wealth Managers Inc. raised its holdings in shares of HCA Healthcare by 14.4% in the 3rd quarter. Valley Wealth Managers Inc. now owns 1,383 shares of the company’s stock valued at $562,000 after purchasing an additional 174 shares during the period. Finally, Empowered Funds LLC increased its position in HCA Healthcare by 10.2% during the third quarter. Empowered Funds LLC now owns 21,824 shares of the company’s stock worth $8,870,000 after buying an additional 2,019 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 0.7 %

Shares of HCA opened at $342.96 on Friday. HCA Healthcare, Inc. has a 52-week low of $238.82 and a 52-week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The business’s fifty day moving average is $385.11 and its 200-day moving average is $357.58. The firm has a market cap of $86.87 billion, a price-to-earnings ratio of 15.40, a PEG ratio of 1.32 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.77%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Analyst Ratings Changes

A number of research analysts recently weighed in on HCA shares. Morgan Stanley initiated coverage on HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 1st. Leerink Partners increased their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Wells Fargo & Company upped their target price on HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 6th. Finally, KeyCorp reduced their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Five research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.00.

Insider Activity

In other news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,155 shares of company stock worth $5,608,990. Insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.